Zobrazeno 1 - 10
of 458
pro vyhledávání: '"Van Gulck, E."'
Autor:
De Pooter D; Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium., De Clerck B; Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium., Dockx K; Charles River Laboratories, Beerse, Belgium., De Santis D; Charles River Laboratories, Beerse, Belgium., Sauviller S; Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium., Dehertogh P; Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium., Beyens M; Discovery Technologies & Molecular Pharmacology, Therapeutics Discovery, Janssen Research and Development, Beerse, Belgium., Bergiers I; Discovery Technologies & Molecular Pharmacology, Therapeutics Discovery, Janssen Research and Development, Beerse, Belgium., Nájera I; Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, California, Brisbane, United States of America., Van Gulck E; Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium., Conceição-Neto N; Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium., Pierson W; Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium.
Publikováno v:
PloS one [PLoS One] 2024 Aug 22; Vol. 19 (8), pp. e0304063. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).
Autor:
Van Gulck E, Pardons M, Nijs E, Verheyen N, Dockx K, Van Den Eynde C, Battivelli E, Vega J, Florence E, Autran B, Archin NM, Margolis DM, Katlama C, Hamimi C, Van Den Wyngaert I, Eyassu F, Vandekerckhove L, Boden D
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Aug 07; Vol. 68 (8), pp. e0081924. Date of Electronic Publication: 2024 Jul 02.
Autor:
Raines SLM; Department of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Falcinelli SD; Department of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Peterson JJ; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Van Gulck E; Janssen Infectious Diseases, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium., Allard B; Department of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Kirchherr J; Department of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Vega J; Arcturus Therapeutics, Science Center Drive, San Diego, California, USA., Najera I; Janssen Infectious Diseases, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium., Boden D; Janssen Infectious Diseases, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium., Archin NM; Department of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Margolis DM; Department of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jul 09; Vol. 68 (7), pp. e0020124. Date of Electronic Publication: 2024 Jun 03.
Autor:
Pardons M; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000, Ghent, Belgium., Cole B; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000, Ghent, Belgium., Lambrechts L; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000, Ghent, Belgium.; BioBix, Department of Data Analysis and Mathematical Modelling, Faculty of Bioscience Engineering, Ghent University, 9000, Ghent, Belgium., van Snippenberg W; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000, Ghent, Belgium., Rutsaert S; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000, Ghent, Belgium., Noppe Y; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000, Ghent, Belgium., De Langhe N; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000, Ghent, Belgium., Dhondt A; Department of Nephrology, Ghent University Hospital, 9000, Ghent, Belgium., Vega J; Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, 92121, CA, USA., Eyassu F; Computational biology, Johnson and Johnson, 2340, Beerse, Belgium., Nijs E; Janssen infectious diseases and diagnostics, Johnson and Johnson, 2340, Beerse, Belgium., Van Gulck E; Janssen infectious diseases and diagnostics, Johnson and Johnson, 2340, Beerse, Belgium., Boden D; Janssen Biopharma, Johnson and Johnson, South San Francisco, 94080, CA, USA., Vandekerckhove L; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, 9000, Ghent, Belgium. linos.vandekerckhove@ugent.be.
Publikováno v:
Nature communications [Nat Commun] 2023 Dec 18; Vol. 14 (1), pp. 8397. Date of Electronic Publication: 2023 Dec 18.
Autor:
De Pooter D; Infectious Diseases Discovery, Janssen Research & Development, LLC, a Johnson & Johnson Company, Turnhoutseweg 30, 2340 Beerse, Belgium., Pierson W; Infectious Diseases Discovery, Janssen Research & Development, LLC, a Johnson & Johnson Company, Turnhoutseweg 30, 2340 Beerse, Belgium., Pourshahian S; RNA and Targeted Therapeutics, Johnson & Johnson Innovative Medicine, 1600 Sierra Point Parkway, Brisbane, CA 94005, USA., Dockx K; Charles River Laboratories, Turnhoutseweg 30, 2340 Beerse, Belgium., De Clerck B; Infectious Diseases Discovery, Janssen Research & Development, LLC, a Johnson & Johnson Company, Turnhoutseweg 30, 2340 Beerse, Belgium., Najera I; Infectious Diseases Discovery, Janssen Research & Development, LLC, a Johnson & Johnson Company, 1600 Sierra Point Parkway, Brisbane, CA 94005, USA., Davis H; Infectious Diseases Discovery, Janssen Research & Development, LLC, a Johnson & Johnson Company, Turnhoutseweg 30, 2340 Beerse, Belgium., Van Gulck E; Infectious Diseases Discovery, Janssen Research & Development, LLC, a Johnson & Johnson Company, Turnhoutseweg 30, 2340 Beerse, Belgium., Boden D; Infectious Diseases Discovery, Janssen Research & Development, LLC, a Johnson & Johnson Company, 1600 Sierra Point Parkway, Brisbane, CA 94005, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Feb 25; Vol. 12 (3). Date of Electronic Publication: 2024 Feb 25.
Autor:
Van Gulck E; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Conceição-Neto N; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Aerts L; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Pierson W; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Verschueren L; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Vleeschouwer M; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Krishna V; Infectious Diseases and Vaccines, Janssen Research and Development, 1400 McKean Road, Springhouse, PA 19002, USA., Nájera I; Infectious Diseases and Vaccines, Janssen Research and Development, 1600 Sierra Point Parkway, South San Fransisco, CA 94005, USA., Pauwels F; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
Publikováno v:
Viruses [Viruses] 2024 Feb 23; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 23.
Autor:
Pardons, M., Cole, B., Lambrechts, L., Rutsaert, S., Noppe, Y., Vega, J., Nijs, E., Van Gulck, E., Boden, D., Vandekerckhove, L.
Publikováno v:
In Journal of Virus Eradication December 2022 8 Supplement
Autor:
Conceição-Neto N; Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Pierson W; Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Vacca M; Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Beyens M; Discovery Therapeutics and Molecular Pharmacology, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., De Clerck B; Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Aerts L; Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Voeten B; Charles River Laboratories, Turnhoutseweg 30, 2340 Beerse, Belgium., De Pooter D; Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Verschueren L; Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Dockx K; Charles River Laboratories, Turnhoutseweg 30, 2340 Beerse, Belgium., Vandenberk M; Charles River Laboratories, Turnhoutseweg 30, 2340 Beerse, Belgium., De Troyer E; SDS Discovery Statistics, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Verwilt K; Discovery Therapeutics and Molecular Pharmacology, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Van Hove C; Discovery Therapeutics and Molecular Pharmacology, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Verslegers M; Preclinical Sciences and Translational Safety (PSTS) Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Bosseler L; Preclinical Sciences and Translational Safety (PSTS) Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Crabbe M; SDS Discovery Statistics, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Krishna V; Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, 1400 McKean Road, Spring House, PA 19002, USA., Nájera I; Infectious Diseases and Vaccines, Janssen Research and Development, 1600 Sierra Point Parkway, South San Francisco, CA 94005, USA., Van Gulck E; Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
Publikováno v:
Vaccines [Vaccines (Basel)] 2023 Dec 06; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 06.
Autor:
Van Gulck E; Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium., Pardons M; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University , Ghent, Belgium., Nijs E; Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium., Verheyen N; Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium., Dockx K; Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium., Van Den Eynde C; Janssen Infectious Diseases, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium., Battivelli E; Janssen Infectious Diseases, A Division of Janssen Pharmaceutica NV , Brisbane, California, USA., Vega J; Arcturus Therapeutics, Science Center Drive , San Diego, California, USA., Florence E; Institute of Tropical Medicine , Antwerp, Belgium., Autran B; Faculty of Medicine Sorbonne-University, CIMI-Paris, UPMC/Inserm , Paris, France., Archin NM; University of North Carolina School of Medicine and UNC, HIV Cure Center , Chapel Hill, North Carolina, USA., Margolis DM; University of North Carolina School of Medicine and UNC, HIV Cure Center , Chapel Hill, North Carolina, USA., Katlama C; Department Infectious Diseases, Hospital Pitié Salpetière, Sorbonne-University and IPLESP , Paris, France., Hamimi C; Faculty of Medicine Sorbonne-University, CIMI-Paris, UPMC/Inserm , Paris, France., Van Den Wyngaert I; Discovery Sciences, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium., Eyassu F; Discovery Sciences, Janssen Research and Development, A Division of Janssen Pharmaceutica NV , Beerse, Belgium., Vandekerckhove L; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University , Ghent, Belgium., Boden D; Janssen Infectious Diseases, A Division of Janssen Pharmaceutica NV , Brisbane, California, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2023 Nov 15; Vol. 67 (11), pp. e0041723. Date of Electronic Publication: 2023 Oct 24.
Publikováno v:
Retrovirology, Vol 6, Iss Suppl 3, p P317 (2009)
Externí odkaz:
https://doaj.org/article/7a8432aa017a4b9aa695e26d346c1fe3